You are here

Contineum Therapeutics

Biopharma IPOs From the First Half of 2024

BioSpace

Thu, 05/30/24 - 11:17 am

Kyverna Therapeutics

ArriVent Biopharma

Alto Neuroscience

Contineum Therapeutics

Rapport Therapeutics

Telix Pharmaceuticals

Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials

BioSpace

Fri, 04/5/24 - 11:32 am

Contineum Therapeutics

neuroinflammation

Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24

Fierce Biotech

Wed, 04/3/24 - 11:36 am

Kyverna Therapeutics

Contineum Therapeutics

CymaBay Therapeutics

Gilead Sciences

Fusion Pharmaceuticals

Neuro and inflammation biotech Contineum Therapeutics sets terms for $150 million IPO

Renaissance Capital

Mon, 04/1/24 - 12:25 pm

Contineum Therapeutics

multiple sclerosis

Contineum Therapeutics files for IPO

Stat

Mon, 03/18/24 - 11:01 am

Contineum Therapeutics

Pipeline Therapeutics

small molecule drugs